Human Technology Co Diluted EPS
The Diluted Earnings per Share of Human Technology Co (175140.KQ) as of Oct 14, 2026 is -5,043.83 KRW. In the previous year, Diluted Earnings per Share was -4,403.36 KRW — a change of 14.54% (lower).
Get this data via API
Financial Data API
Diluted EPS
-5,043.83KRW
YoY
14.54%
Last updated:
The Human Technology Co Diluted EPS history
3 Years
10 Years
25 Years
Max
| YEAR | Diluted EPS | YoY |
|---|---|---|
| -5,043.83KRW | +14.54% | |
| -4,403.36KRW | +12.75% | |
| -3,905.50KRW | +38.23% | |
| -2,825.38KRW | +66.42% | |
| -1,697.73KRW | -43.66% | |
| -3,013.63KRW | +3.06% | |
| -2,924.23KRW | -8,622.30% | |
| 34.31KRW | -101.73% | |
| -1,983.21KRW | -764.42% | |
| 298.49KRW | -259.69% | |
| -186.92KRW | -116.55% | |
| 1,129.66KRW | — |
Human Technology Co Stock analysis
Frequently Asked Questions about Human Technology Co stock
Diluted Earnings per Share of Human Technology Co is -5,043.83 KRW in 2025.
Diluted Earnings per Share of Human Technology Co changed from -4,403.36 KRW to -5,043.83 KRW, representing a 14.54% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Diluted Earnings per Share Human Technology Co since 2006 – with annual values, charts, and detailed analysis.
Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.
Income Statement — Human Technology Co
All Key Metrics — Human Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth